| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |